Tumor necrosis factor activates human endothelial cells through the p55 tumor necrosis factor receptor but the p75 receptor contributes to activation at low tumor necrosis factor concentration
about
Tumor necrosis factor disrupts claudin-5 endothelial tight junction barriers in two distinct NF-κB-dependent phasesEtk/Bmx as a tumor necrosis factor receptor type 2-specific kinase: role in endothelial cell migration and angiogenesisCirculating TNF receptors predict cardiovascular disease in patients with chronic kidney disease.The function of tumour necrosis factor and receptors in models of multi-organ inflammation, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease.Targeting of tumor necrosis factor receptor 1 to low density plasma membrane domains in human endothelial cells.Immunogenetic biomarkers in inflammatory bowel diseases: role of the IBD3 region.Endothelial activation: intracellular signaling pathwaysHapten application to the skin induces an inflammatory program directing hapten-primed effector CD8 T cell interaction with hapten-presenting endothelial cellsPlasma membrane microdomains regulate TACE-dependent TNFR1 shedding in human endothelial cells.Tumor necrosis factor alpha (TNF-alpha) receptor-II is required for TNF-alpha-induced leukocyte-endothelial interaction in vivo.Disparate localization of 55-kd and 75-kd tumor necrosis factor receptors in human endothelial cells.Circulating TNF receptors 1 and 2 predict stage 3 CKD in type 1 diabetes.Tumor necrosis factor-α induces sensitization of meningeal nociceptors mediated via local COX and p38 MAP kinase actionsActivation and homologous desensitization of human endothelial cells by CD40 ligand, tumor necrosis factor, and interleukin 1.A human tumor necrosis factor p75 receptor agonist stimulates in vitro T cell proliferation but does not produce inflammation or shock in the baboonTarget effector role of vascular endothelium in the inflammatory response: insights from the clinical trial of anti-TNF alpha antibody in rheumatoid arthritisHuman stanniocalcin-1 blocks TNF-alpha-induced monolayer permeability in human coronary artery endothelial cells.Tumor necrosis factor (TNF)-alpha activates c-raf-1 kinase via the p55 TNF receptor engaging neutral sphingomyelinase.Adipokines: a link between obesity and cardiovascular disease.Antiangiogenic therapy and mechanisms of tumor resistance in malignant glioma.Recent advances in cytokines: therapeutic implications for inflammatory bowel diseases.The antitumour activity of 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in TNF receptor-1 knockout mice.Breaking the 'harmony' of TNF-α signaling for cancer treatmentPeriodontitis-activated monocytes/macrophages cause aortic inflammation.Characterization of TNF receptor subtype expression and signaling on pulmonary endothelial cells in mice.Immunofluorescent localisation of tumour necrosis factor-alpha receptors on the popliteal lymph node and the surrounding adipose tissue following a simulated immune challenge.Effect of human cytokines (IFN-gamma, TNF-alpha, IL-1 beta, IL-4) on porcine endothelial cells: induction of MHC and adhesion molecules and functional significance of these changes
P2860
Q24324864-D96FB439-6520-472A-8B5C-0B07CE5078C4Q24540207-859B87F9-98AD-416D-8025-66474695ECB6Q33672484-4FB0F1D8-A708-46B7-A8AC-5F3DFF57CB92Q33782327-76ABAC72-E2C3-4799-B12E-49579EAA2E63Q34025245-0B582C63-4DBF-4AA9-8972-50327B5305ECQ34467128-C9BAA397-1C6D-4500-A71D-C711B71F8368Q34731148-DE5551FD-BB8E-47DF-AE1F-FE213A255EBBQ35300873-360D2EBD-E0AD-43D9-8319-9DA42755B184Q35456998-9CC8998C-3415-4DD8-A73F-DA8F535ADD5AQ35642831-24063CDF-B043-49AD-AC23-CF1525B05377Q35797945-081F9CDE-2C0B-4C15-B609-F1526F944972Q35804154-E22CC06B-E265-4732-8716-5CB82D7D23EDQ36082146-ECAD6A8E-36FF-486E-B8A2-87FBD9256B8AQ36367016-DF5293D3-559D-43FD-9EC0-FB5A31A3A402Q36367041-98745182-2025-4892-987C-4DFC48FBD2C8Q37229283-93919359-2803-4312-BADB-48F5FDBB3A97Q37317968-A5AF2FD5-F01C-4C98-B1C7-07888E9FA3C4Q37695056-816104C0-4ED5-4020-BB5D-C40326F5AC3EQ37707281-DF5C3C45-8DA3-41DC-936E-37E38455DC4DQ37736273-6886B4BE-7141-4C39-A40E-F0F72CC9D9F2Q37847059-3F8FEAF9-E125-4EF5-9BFB-D2B3A7799839Q38289597-C812EF5E-D5B5-416F-81E7-6278BC5BC414Q38410101-02793024-7E2C-4C89-A302-2C089CCB025BQ40275695-6C10C3B3-80CC-448D-B437-96DDB17BEC60Q42241985-3E1C83F7-8702-4842-AAD3-38F19933D66FQ42679811-38AD02C0-F61D-4810-A773-4E183CEEA204Q56909183-CFE95CC8-3734-448C-8FCE-E4D6B12D837E
P2860
Tumor necrosis factor activates human endothelial cells through the p55 tumor necrosis factor receptor but the p75 receptor contributes to activation at low tumor necrosis factor concentration
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Tumor necrosis factor activate ...... necrosis factor concentration
@en
Tumor necrosis factor activate ...... necrosis factor concentration
@nl
type
label
Tumor necrosis factor activate ...... necrosis factor concentration
@en
Tumor necrosis factor activate ...... necrosis factor concentration
@nl
prefLabel
Tumor necrosis factor activate ...... necrosis factor concentration
@en
Tumor necrosis factor activate ...... necrosis factor concentration
@nl
P2093
P2860
P1476
Tumor necrosis factor activate ...... necrosis factor concentration
@en
P2093
P2860
P304
P407
P577
1993-12-01T00:00:00Z